Verona Pharma Share Discussion Threads

[bonzo] 17/7/2020 12:59

There's a systemic bias against this class of compound which goes back a long way, I think this has put the big companies off...

[murphy2000] 17/7/2020 12:58

£10 plus would be very very nice, £3 by Christmas more realistic but if as you say the trials go well and they get approval, anything and everything is possibly. Tightly held! They raised £200 million yet market cap is £100m at app £1.00. Long way to go

[goggin] 17/7/2020 12:34

Lots of resistance around 3 £, after that it hit? Its all time high of 10.56 £ was on 1st sept 09, will it get there again? Most certainly on positive results and if Ensifentrine gets regulatory approval, who knows where a tightly held stock could go.

[lukic] 17/7/2020 12:28

Good call ;-)

[rk23] 17/7/2020 11:48

This looks good for 95-100 today.

[ewads] 17/7/2020 08:16

Results from Phase 1/11 has been good/v good. Surprised if one big pharma has not considered taking up the baton from here.

[bonzo] 17/7/2020 08:06

Unlikely to be early news from a phase 3 trial unless they use an adaptive design which gives an early indication of efficacy, or get an outstanding response which effectively unblinded the study.

[joeblogg2] 17/7/2020 07:12

Great news!!!

[goggin] 17/7/2020 07:09

200 million - this sorts out Hugh uncertainty

[ewads] 17/7/2020 07:04

This injection is a massive vote of confidence for the credibility for the expected success of the company

[goggin] 17/7/2020 06:48

Woh, this removes uncertainty short term, any positive news and this will go crazy. It's positive news, they needed the cash big time. Could easily hit £7 plus if Ensifentrine hits the sweet spot

[pjm1162] 17/7/2020 06:18

Another substantial ammount raised at 0.45Not a great price.Still gonna be years away and another 200 million needed later down the lineGonna be dead by the time this company has anything real to show.Jobs for the boys, good salaries for all of them so no incentive to get a move on

[bonzo] 17/7/2020 06:13

Inevitable dilution fir existing holders and not much price action until the Phase 3 outcome is known, I suspect.

[haff1] 12/6/2020 10:58

...its hard to express what a dissappointing little scam of a share this is? Its always jam tomorrow then its diluted or retraced! Ive seen this over the 10 years I've been involved!

[wageslave] 12/6/2020 10:22

Shared normally perks up close to a fund raise to get a better price. Only a possibility, but could happen here.

[tradertrev] 12/6/2020 07:58

shakin, in my opinion the pending fund raise is a huge overhang which everyone knows about and will be tightly held by anyone who takes part, being the last fund raise before phase 3 trial results are known. The market can then focus on the commercial opportunity which is vast, so the chances of buying shares in the market below any offer price would appear to be slim.

[shakin not stirred] 12/6/2020 07:09

dilution on the way I reckon. Phase 3 starting end of third quarter and need to find over 90 million. The next global funding will be at a ridiculously low price but if given the chance to take part I will give it a big miss. Just wait for new shares to enter market and wait for inevitable drop of share price below offer and pick some up then

[goggin] 10/6/2020 17:51

https://copdnewstoday.com/2020/03/26/copd-patients-vulnerable-to-severe-covid-19-infections-study-finds/

[tradertrev] 30/5/2020 08:34

Could be ahead of webcast on Monday at 12.30pm to present the Phase 3 trial programme and the huge commercial case for enisfentrine. Should be positive IMO.

[mark205] 29/5/2020 10:06

No idea.Big money has other ideas. £52+ buys yesterday.MMs gave me a top up 2p below the bid so they could disguise it as a sell. Up 10% profit straight away.Very strange but I'm in. Something going on. Leaky!

[wageslave] 29/5/2020 09:25

Bit of a bounce here last couple of days. Any idea why?

[slicethepie] 12/5/2020 16:36

7% dilution! It would be good to see them put some of their own capital at risk but that seems unlikely.

[slicethepie] 30/4/2020 16:07

I think there is some fantastic science here unfortunately that doesn't always translate into shareholder returns. I had hoped the new team would be a bit more aware of and have respect for who is providing the risk capital.